Eli Lilly and Company
Amino pyrimidine SSAO inhibitors
Last updated:
Abstract:
The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of treating patients for liver disease, and processes for preparing the compounds.
Status:
Grant
Type:
Utility
Filling date:
18 Mar 2019
Issue date:
5 Nov 2019